AEMD Stock Overview
A medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Aethlon Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.80 |
| 52 Week High | US$2.14 |
| 52 Week Low | US$0.24 |
| Beta | 1.62 |
| 1 Month Change | 104.87% |
| 3 Month Change | 101.51% |
| 1 Year Change | -60.78% |
| 3 Year Change | -95.58% |
| 5 Year Change | -95.74% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Aug 02
FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID
Jul 11We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Mar 18We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow
Nov 09Aethlon Medical climbs on Reddit interest
Jun 09We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
May 12We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely
Jan 27Aethlon Medical has a new business and medical chief
Jan 06Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment
Dec 16Aethlon names Charles J. Fisher, Jr., M.D. as CEO
Nov 03Shareholder Returns
| AEMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 21.1% | -0.3% | -0.2% |
| 1Y | -60.8% | 11.3% | 25.8% |
Return vs Industry: AEMD underperformed the US Medical Equipment industry which returned 11.3% over the past year.
Return vs Market: AEMD underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| AEMD volatility | |
|---|---|
| AEMD Average Weekly Movement | 29.0% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AEMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AEMD's weekly volatility has increased from 21% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 14 | Jim Frakes | www.aethlonmedical.com |
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Aethlon Medical, Inc. Fundamentals Summary
| AEMD fundamental statistics | |
|---|---|
| Market cap | US$11.17m |
| Earnings (TTM) | -US$11.27m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.0x
P/E RatioIs AEMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AEMD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$11.27m |
| Earnings | -US$11.27m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.81 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did AEMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 09:33 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aethlon Medical, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vernon Bernardino | H.C. Wainwright & Co. |
| Anthony Vendetti | Maxim Group |
| Ajay Tandon | SeeThruEquity, LLC |